Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis

15 Jul 2016

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Electrolyte and hormonal disorders
Share to Liver Disease and Transplantation
Share to Neuroendocrine regulation and behavior

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 27422752
DOI: 10.1016/j.jhep.2016.07.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Plasma copeptin as biomarker of disease progression and prognosis in cirrhosisPMID 27422752Read ↗

Heart Rate Variability in Patients with Cirrhosis: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Predictive value of serum amino acids as metabolite biomarkers in cirrhosis: a systematic review and meta-analysisSemantic proximity Read ↗

Early Identification of At-Risk Patients: Proteomic Signature Predicts Progression to Decompensated CirrhosisSemantic proximity Read ↗

Plasma miRNA-122-5p and miRNA-151a-3p identified as potential biomarkers for liver injury among CHB patients with PNALTSemantic proximity Read ↗

Chronic hepatitis D in Austria: high burden of cirrhosis and portal hypertension, IL28B C/C as unfavorable factor, increased systemic inflammation in decompensation.Semantic proximity Read ↗

Dynamic network biomarker analysis and system pharmacology methods to explore the therapeutic effects and targets of Xiaoyaosan against liver cirrhosisSemantic proximity Read ↗

Lp-Pla2 As A Biomarker and Its Possible Associations with Sars-Cov-2 InfectionSemantic proximity Read ↗

Circulating Lipids Predict Mortality and Drive Immune Gene Regulation in Acute-on-Chronic Liver FailureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.